Opioids
The Substance Abuse and Mental Health Services Administration will launch a three-part virtual learning series on recovery supports for people considering or using medication-assisted treatment for opioid use disorder or co-occurring disorders.
Drug overdose deaths declined 5.1% in 2018 to about 68,000, according to preliminary data from the Centers for Disease Control and Prevention.
The AHA Physician Alliance explores some of the key elements driving the success of the Prescribe Safe Initiative, an extremely successful community-based project bringing together law enforcement, hospitals and physicians to reduce prescription medication misuse.
Under a new Centers for Medicare & Medicaid Services proposal, Medicare would cover acupuncture as an alternative to opioid use for beneficiaries with chronic low back pain who are enrolled in a qualified study.
Six health care organizations in rural North Carolina communities will share $1.2 million in federal grant funds to strengthen and expand their response to opioid use disorder with increased planning; prevention; evidence-based treatment, including medication-assisted treatment; and recovery…
The Food and Drug Administration yesterday released new draft guidance for labeling medications that carry the risk of abuse or dependence, including but not limited to opioids, and simplifying labels with complicated usage instructions.
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic will host a free public webinar July 22 at 3 p.m. ET on best practices and evidence standards for opioid tapering.
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders.
The House Committee on Oversight and Reform today held the third in a series of hearings examining solutions to the opioid epidemic, which focused on the adequacy of the federal response and on legislation to expand access to evidence-based treatment for substance use disorders.
The Food and Drug Administration today published a notice seeking comment through July 30 on a potential change to the Opioid Analgesic Risk Evaluation and Mitigation Strategy.